Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satya Dash

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Diabetes, Obesity & Metabolism|March 15, 2018
Effects of intranasal insulin on endogenous glucose production in insulin-resistant menChangting Xiao, Satya Dash, Priska Stahel, et al.
Canadian Journal of Diabetes|March 9, 2026
Insulin response to glucose and type 2 diabetes and its impact on cardiometabolic disease: a sex-stratified Mendelian randomization study to assess potential causalityYuchao Wu, Habiba Hashemy, Andrew D Paterson, et al.
The Canadian Journal of Cardiology|July 10, 2023
Biology and Clinical Use of Glucagon-Like Peptide-1 Receptor Agonists in Vascular ProtectionKevin Yau, Ayodele Odutayo, Satya Dash, et al.
Diabetes|October 8, 2014
Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrationsSatya Dash, Changting Xiao, Cecilia Morgantini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 28, 2013
High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese menSatya Dash, Changting Xiao, Cecilia Morgantini, et al.
The Journal of Clinical Endocrinology and Metabolism|May 29, 2015
Is Insulin Action in the Brain Relevant in Regulating Blood Glucose in Humans?Satya Dash, Changting Xiao, Cecilia Morgantini, et al.
Diabetes|March 11, 2015
Evaluation of the Effect of Enteral Lipid Sensing on Endogenous Glucose Production in HumansChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Diabetes|June 25, 2015
Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein MetabolismChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Diabetes|June 23, 2016
Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL CholesterolChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Diabetes|March 4, 2014
Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humansChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Diabetes, Obesity & Metabolism|March 15, 2018
Effects of intranasal insulin on endogenous glucose production in insulin-resistant menChangting Xiao, Satya Dash, Priska Stahel, et al.
Canadian Journal of Diabetes|March 9, 2026
Insulin response to glucose and type 2 diabetes and its impact on cardiometabolic disease: a sex-stratified Mendelian randomization study to assess potential causalityYuchao Wu, Habiba Hashemy, Andrew D Paterson, et al.
The Canadian Journal of Cardiology|July 10, 2023
Biology and Clinical Use of Glucagon-Like Peptide-1 Receptor Agonists in Vascular ProtectionKevin Yau, Ayodele Odutayo, Satya Dash, et al.
Diabetes|October 8, 2014
Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrationsSatya Dash, Changting Xiao, Cecilia Morgantini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 28, 2013
High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese menSatya Dash, Changting Xiao, Cecilia Morgantini, et al.
The Journal of Clinical Endocrinology and Metabolism|May 29, 2015
Is Insulin Action in the Brain Relevant in Regulating Blood Glucose in Humans?Satya Dash, Changting Xiao, Cecilia Morgantini, et al.
Diabetes|March 11, 2015
Evaluation of the Effect of Enteral Lipid Sensing on Endogenous Glucose Production in HumansChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Diabetes|June 25, 2015
Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein MetabolismChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Diabetes|June 23, 2016
Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL CholesterolChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Diabetes|March 4, 2014
Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humansChangting Xiao, Satya Dash, Cecilia Morgantini, et al.
Pageof 7